NKG2D CAR-T KD-025

· Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKG2D CAR-T KD-025, covering 2024-07-19 to 2024-07-19. Get the full timeline:

Most recent: Clinical Trial Update: NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors [NA]